194 related articles for article (PubMed ID: 18492671)
1. Translational medicine: cancer pain mechanisms and management.
Delaney A; Fleetwood-Walker SM; Colvin LA; Fallon M
Br J Anaesth; 2008 Jul; 101(1):87-94. PubMed ID: 18492671
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor modulates N-methyl-D-aspartate receptor activation in a rat model of cancer-induced bone pain.
Wang LN; Yang JP; Ji FH; Zhan Y; Jin XH; Xu QN; Wang XY; Zuo JL
J Neurosci Res; 2012 Jun; 90(6):1249-60. PubMed ID: 22354476
[TBL] [Abstract][Full Text] [Related]
4. Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study.
Michael N; Sulistio M; Wojnar R; Gorelik A
BMC Palliat Care; 2023 Apr; 22(1):42. PubMed ID: 37059995
[TBL] [Abstract][Full Text] [Related]
5. New insights of nociceptor sensitization in bone cancer pain.
Hua B; Gao Y; Kong X; Yang L; Hou W; Bao Y
Expert Opin Ther Targets; 2015 Feb; 19(2):227-43. PubMed ID: 25547644
[TBL] [Abstract][Full Text] [Related]
6. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain.
Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK
Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.
Scarpi E; Calistri D; Klepstad P; Kaasa S; Skorpen F; Habberstad R; Nanni O; Amadori D; Maltoni M
Oncologist; 2014 Dec; 19(12):1276-83. PubMed ID: 25342315
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Spinal Bv8/Prokineticin 2 in a Rat Model of Cancer-Induced Bone Pain.
Hang LH; Luo H; Li SN; Shu WW; Chen Z; Chen YF; Yuan JF; Shi LL; Shao DH
Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):180-5. PubMed ID: 25641661
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Mechanism of Cancer-Induced Bone Pain.
Yang Y; Yang W; Zhang R; Wang Y
Neurosci Bull; 2024 Jun; 40(6):815-830. PubMed ID: 37798428
[TBL] [Abstract][Full Text] [Related]
11. Malignant bone pain: pathophysiology and treatment.
Mercadante S
Pain; 1997 Jan; 69(1-2):1-18. PubMed ID: 9060007
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Sensory Testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response.
Scott AC; McConnell S; Laird B; Colvin L; Fallon M
Eur J Pain; 2012 Jan; 16(1):123-33. PubMed ID: 21658980
[TBL] [Abstract][Full Text] [Related]
13. Analgesic effect of quetiapine in a mouse model of cancer-induced bone pain.
Heo MH; Kim JY; Hwang I; Ha E; Park KU
Korean J Intern Med; 2017 Nov; 32(6):1069-1074. PubMed ID: 28103434
[TBL] [Abstract][Full Text] [Related]
14. Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer.
Thompson ML; Jimenez-Andrade JM; Chartier S; Tsai J; Burton EA; Habets G; Lin PS; West BL; Mantyh PW
Pain; 2015 Sep; 156(9):1692-1702. PubMed ID: 25993548
[TBL] [Abstract][Full Text] [Related]
15. The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain.
Habberstad R; Frøseth TCS; Aass N; Abramova T; Baas T; Mørkeset ST; Caraceni A; Laird B; Boland JW; Rossi R; Garcia-Alonso E; Stensheim H; Loge JH; Hjermstad MJ; Bjerkeset E; Bye A; Lund JÅ; Solheim TS; Vagnildhaug OM; Brunelli C; Damås JK; Mollnes TE; Kaasa S; Klepstad P
BMC Palliat Care; 2018 Sep; 17(1):110. PubMed ID: 30266081
[TBL] [Abstract][Full Text] [Related]
16. Minocycline-induced reduction of brain-derived neurotrophic factor expression in relation to cancer-induced bone pain in rats.
Wang LN; Yang JP; Zhan Y; Ji FH; Wang XY; Zuo JL; Xu QN
J Neurosci Res; 2012 Mar; 90(3):672-81. PubMed ID: 22057846
[TBL] [Abstract][Full Text] [Related]
17. P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
Chen J; Wang L; Zhang Y; Yang J
Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):367-72. PubMed ID: 22349022
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of cancer-induced bone pain: current understanding.
Urch C
Palliat Med; 2004 May; 18(4):267-74. PubMed ID: 15198116
[TBL] [Abstract][Full Text] [Related]
19. P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain.
Jin XH; Wang LN; Zuo JL; Yang JP; Liu SL
J Neurosci Res; 2014 Dec; 92(12):1690-702. PubMed ID: 24984884
[TBL] [Abstract][Full Text] [Related]
20. The management of pain in metastatic bone disease.
Buga S; Sarria JE
Cancer Control; 2012 Apr; 19(2):154-66. PubMed ID: 22487978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
